Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 194,238
  • Shares Outstanding, K 48,198
  • Annual Sales, $ 20 K
  • Annual Income, $ -16,100 K
  • 60-Month Beta 1.82
  • Price/Sales 27,697.50
  • Price/Cash Flow N/A
  • Price/Book 10.31
Trade VNRX with:

Options Overview

Details
  • Implied Volatility 98.07%
  • Historical Volatility 103.50%
  • IV Percentile 7%
  • IV Rank 18.62%
  • IV High 703.90% on 07/10/20
  • IV Low 51.90% on 07/13/20
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 131
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 1,274

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.10
  • Number of Estimates 1
  • High Estimate -0.10
  • Low Estimate -0.10
  • Prior Year -0.09
  • Growth Rate Est. (year over year) -11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.95 +0.25%
on 03/03/21
6.67 -40.63%
on 02/09/21
-1.45 (-26.80%)
since 02/03/21
3-Month
3.30 +20.00%
on 12/08/20
6.67 -40.63%
on 02/09/21
+0.56 (+16.47%)
since 12/03/20
52-Week
2.22 +78.38%
on 03/18/20
6.67 -40.63%
on 02/09/21
+0.14 (+3.66%)
since 03/03/20

Most Recent Stories

More News
Proactive news headlines including Alpine 4 Technologies, Aequus Pharmaceuticals, Aurania Resources and VolitionRx

- Alpine 4 Technologies Ltd (OTCQB:ALPP) enters definitive agreements for registered direct offering for gross proceeds of approximately $50M click here

AQS.VN : 0.250 (-7.41%)
ALPP : 5.0500 (-13.38%)
AQSZF : 0.1889 (-14.14%)
VLNCF : 1.3900 (-0.71%)
LXXGF : 0.8350 (-5.59%)
ARU : 25.20 (-0.32%)
AUIAF : 2.5320 (-0.96%)
NUAG : 24.89 (-0.36%)
NUPMF : 4.7671 (-6.71%)
VR.CN : 0.080 (+6.67%)
VRCFF : 0.0673 (+13.11%)
RDY.CN : 0.340 (unch)
VNRX : 3.94 (-2.23%)
AREB : 0.0750 (unch)
VolitionRx Limited Announces Closing of $20 Million Underwritten Public Offering of Common Stock

, /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy...

VNRX : 3.94 (-2.23%)
VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock

, /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy...

VNRX : 3.94 (-2.23%)
VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock

, /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy...

VNRX : 3.94 (-2.23%)
Small and Microcap Company Investor Presentations Now Available for On-Demand Viewing

, /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the Small and Microcap Showcase are now available for...

BIGG.CN : 1.430 (+10.00%)
NTAR.CN : 5.180 (-2.26%)
MIRI.LN : 53.400 (+0.75%)
BBKCF : 1.1313 (+9.16%)
EXPFF : 0.3123 (-6.19%)
MMDDF : 0.6970 (+2.50%)
NEXCF : 4.1000 (-1.44%)
ALVOF : 0.6908 (+10.30%)
ETIHY : 3.9000 (unch)
LLEIF : 7.9300 (unch)
GNPX : 5.42 (-3.90%)
BSGM : 4.51 (-1.31%)
VNRX : 3.94 (-2.23%)
CTXR : 1.95 (-3.47%)
VERB : 2.03 (-2.40%)
LGIQ : 6.9300 (-3.48%)
CETY : 0.0895 (+5.29%)
SLBG : 3.0300 (-10.09%)
SKYE : 0.0910 (+1.11%)
VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts

, /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today provided a business update and announced the appointment of a new Chief Financial Officer, Mr. Terig Hughes, in addition to...

VNRX : 3.94 (-2.23%)
VolitionRx Limited to Webcast Live at VirtualInvestorConferences.com February 4th

, /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers...

VNRX : 3.94 (-2.23%)
Live Investor Conference & Webinar: Small and Microcap Company Showcase on February 4th

, /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Small and Microcap Showcase.  Individual investors, institutional...

VNRX : 3.94 (-2.23%)
BIGG.CN : 1.430 (+10.00%)
MIRI.LN : 53.400 (+0.75%)
BSGM : 4.51 (-1.31%)
GNPX : 5.42 (-3.90%)
VERB : 2.03 (-2.40%)
CTXR : 1.95 (-3.47%)
EMBI : 0.0900 (+1.69%)
SKYE : 0.0910 (+1.11%)
BBKCF : 1.1313 (+9.16%)
CETY : 0.0895 (+5.29%)
EXPFF : 0.3123 (-6.19%)
MMDDF : 0.6970 (+2.50%)
SLBG : 3.0300 (-10.09%)
ALVOF : 0.6908 (+10.30%)
ETIHY : 3.9000 (unch)
LGIQ : 6.9300 (-3.48%)
LLEIF : 7.9300 (unch)
National Taiwan University Hospital Presents Data on Nu.Q™ Assay Performance at the World Conference on Lung Cancer

, /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers...

VNRX : 3.94 (-2.23%)
VolitionRx Limited Opens its New Manufacturing Facility in Belgium

, /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the opening of "Silver One", its 10,000 square foot dedicated manufacturing facility located on the same science...

VNRX : 3.94 (-2.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer...

See More

Key Turning Points

3rd Resistance Point 4.35
2nd Resistance Point 4.28
1st Resistance Point 4.16
Last Price 3.94
1st Support Level 3.97
2nd Support Level 3.90
3rd Support Level 3.78

See More

52-Week High 6.67
Fibonacci 61.8% 4.97
Fibonacci 50% 4.45
Last Price 3.94
Fibonacci 38.2% 3.92
52-Week Low 2.22

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar